Editors-in-Chief
- Edward Abraham, Wake Forest School of Medicine
- Zhinan Chen, Fourth Military Medical University
- Francesco Marincola, National Institutes of Health
- Xiangdong Wang, Fudan University
- Elias Zerhouni, Johns Hopkins University School of Medicine
Society affiliations
Clinical and Translational Medicine is affiliated with the International Society for Translational Medicine.
Articles
-
Research
Clinical and Translational Medicine 2013, 2:12 (17 June 2013)A pilot study demonstrating a non-invasive method for the measurement of protein turnover in skin disorders: application to psoriasis
-
Review
Clinical and Translational Medicine 2013, 2:11 (21 May 2013)Regenerative medicine for the kidney: stem cell prospects & challenges
-
Perspective
Clinical and Translational Medicine 2013, 2:10 (10 May 2013)Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise
-
Review
Clinical and Translational Medicine 2013, 2:9 (11 April 2013)Treatment of hepatitis C virus infection in the future
- View more articles
Aims & scope
Clinical and Translational Medicine (CTM) aims to play an important and recognized role in reporting knowledge that contributes towards the understanding of molecular mechanisms of disease. CTM also aims to foster a predictive, preventive, personalized and practical approach towards precision medicine, leading to improved patient prognosis. The journal provides a forum for exchange of ideas between basic and clinical scientists on molecular and cellular mechanisms of disease and potential therapies.
Clinical Genomics Section
The section of Clinical Genomics covers clinical and translational science of genetic and genomic research on the area of clinical potentials and applications of genomic technology, genome structure and function, genetic modification, databases, bioinformatics, clinical phenotypes and genotypes, biomarkers, precision medicine, disease genomics, pharmacogenomics, comparative genomics, systems biology, and regulation policy. The section will publish original articles, reviews, editorials, commentaries, bioethics, perspectives, regulations, guidelines, consensus, methodologies, or brief reports/communication associated with clinical potentials and applications of genomics.
For more information please visit: www.clintransmed.com/sections/clinicalgenomics
Quote
"Clinical and Translational Medicine was originally established to promote and help progress the work of translational medicine. We promote research across all fields and wanted it to be available to as many people as possible, so we chose the open access publishing model as it allowed this access without the barrier of a subscription."
Aamir Shahzad, M.D., Secretary General and Director of Administration of the International Society for Translational Medicine said in an interview.
Click here to read more.
About SpringerOpen
SpringerOpen is Springer’s new suite of open access journals which will cover all disciplines.
SpringerOpen journals are fully and immediately open access and will publish articles under the Creative Commons Attribution license.
This makes it easy for authors to fully comply with open access mandates and retain copyright.
SpringerOpen journals combine open access and our expertise in delivering high-quality and rapid publications,
from online submission systems and in-depth peer review to an efficient, author-friendly production process.
SpringerOpen Newsletter
Receive periodic news and updates relating to SpringerOpen.
Indexed by
- DOAJ
- Google Scholar
- OCLC
- PubMed
- PubMed Central
- Scirus
- Summon by Serial Solutions
